EHRA Premium Access

Managing the thromboembolic risk in atrial fibrillation

Event: EHRA 2018
Topic: Miscellaneous
Session type: Moderated Posters
Date: 19 March 2018
Time: 15:35 - 16:25

Congress Session

7 presentations in this session

Incidence of atrial arrhythmia and uptake of anticoagulation in stroke and non-stroke populations according to arrhythmia burden; a 7-year experience.

Speaker: Doctor P. Chousou (Cambridge, GB)
Thumbnail

Relation of Nonsteroidal Anti-Inflammatory Drugs and Time in Therapeutic Range in Bleeding Risk in Atrial Fibrillation: the SPORTIF Trials

Speaker: Doctor M. Proietti (Milan, IT)
Thumbnail

Incidence and predictors of left atrial appendage thrombus in patients treated with direct oral anticoagulants versus warfarin for non-valvular atrial fibrillation

Speaker: Doctor K. Minami (Utsunomiya, JP)
Thumbnail

Left atrial stunning as a predictor of atrial fibrillation occurrence after cryptogenic stroke

Speaker: Doctor J. Farinha (Setubal, PT)
Thumbnail

Indications for and outcome in patients undergoing left atrial appendage closure - Results of the Austrian LAAC Registry

Speaker: Mr D. Zweiker (Vienna, AT)
Thumbnail

Differences in anticoagulation strategy and outcome in patients with atrial fibrillation according to renal function

Thumbnail

Antithrombotic therapy in patients with atrial fibrillation and a so-called temporary cause: a different benefit in case of acute coronary syndrome?

Speaker: Doctor A. Bisson (Tours, FR)
Thumbnail

6 speakers from this session

Doctor Panagiota Anna Chousou

Addenbrooke's Hospital, Cambridge (United Kingdom of Great Britain & Northern Ireland)
2 presentations
0 follower

Doctor Marco Proietti

University of Milan, Milan (Italy)
6 presentations
0 follower

Doctor Kentaro Minami

Dokkyo Medical University, Utsunomiya (Japan)
0 follower

Doctor Jose Maria Farinha

Hospital Center of Setubal, Setubal (Portugal)
0 follower

Mr David Zweiker

Ottakring Clinic, Vienna (Austria)
0 follower

Doctor Arnaud Bisson

CHU de Tours, Tours (France)
0 follower

This platform is supported by

logo Novo Nordisk